Glen Harbor Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Glen Harbor Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$19K	Hold	2,040	–	–	﹤0.01%	1299
2019 Q2	$22K	Buy	+2,040	New	+$21.7K	﹤0.01%	1296
2019 Q1	–	Sell	-27,370	Closed	-$314K	–	1319
2018 Q4	$314K	Sell	27,370 -12,002	-30%	-$149K	0.01%	793
2018 Q3	$668K	Buy	39,372 +18,904	+92%	+$287K	0.01%	598
2018 Q2	$291K	Buy	20,468 +15,368	+301%	+$255K	0.01%	849
2018 Q1	$97K	Buy	+5,100	New	+$109K	﹤0.01%	1157

Other funds holding SGMO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Glen Harbor Capital Management's SGMO Position: Q3 2019 in Review

Glen Harbor Capital Management held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q3 2019 at 2,040 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #1299.

Glen Harbor Capital Management first reported a position in SGMO in Q1 2018 and has held it in 6 quarters since. The position peaked at $668K in Q3 2018. 184 funds tracked by Wall St. Rank hold SGMO as of Q3 2019.

Glen Harbor Capital Management held 2,040 shares of SANGAMO THERAPEUTICS INC worth $19K as of Q3 2019.
Glen Harbor Capital Management left its SANGAMO THERAPEUTICS INC share count unchanged in Q3 2019.
SANGAMO THERAPEUTICS INC made up ﹤0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #1299 holding.
Glen Harbor Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and has held it in 6 quarters since.
Glen Harbor Capital Management's SANGAMO THERAPEUTICS INC position peaked at $668K in Q3 2018.
184 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.